Global Pacemakers Market

Pacemakers Market Size, Share, Growth Analysis, By Product(Implantable pacemakers, and External pacemakers), By Type(MRI Compatible Pacemakers, and Conventional Pacemakers), By Application(Arrhythmias, Congestive Heart Failure, and Others), By End-use(Hospitals & Cardiac Centers, Ambulatory Surgical Centers, and Others), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2628 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 115 | Figures: 77

Pacemakers Market Regional Insights

In 2022, North America held a commanding 42.0% revenue share in the pacemaker market and dominated it. This rise is brought on by an aging population with cardiac issues, the presence of important players, quick technology breakthroughs like Bluetooth-enabled pacemakers and MRI-compatible pacemakers, as well as better regulatory clearances. The incidence of cardiovascular diseases, such as congestive heart failure, cardiac arrests, and arrhythmias, is rising quickly in the United States, which is fueling the need for pacemakers in the country. Technical advancements in the healthcare sector and a rise in the number of heart-related procedures are also driving the market in the area.

The Asia Pacific market is anticipated to grow at an annualized growth rate (CAGR) of roughly 4.0% over the forecasted period. The region's market is expanding as a result of the key players' market penetration as well as several untapped opportunities. Investing in the healthcare sector has also grown in popularity, especially in Japan, China, & India. The development of a strong healthcare system for cardiovascular evaluation and therapy is a growing area of focus for these countries. These elements are anticipated to drive market expansion in the following years. Numerous market opportunities are predicted to arise as a result of the expanding populations and economy of developing countries like China and India.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Pacemakers Market size was valued at USD 4.67 Billion in 2023 and is poised to grow from USD 4.84 Billion in 2024 to USD 6.42 Billion by 2032, growing at a CAGR of 3.6% during the forecast period (2025-2032).

To increase their market penetration, key corporations conducted a variety of strategic efforts, including product launches, acquisitions and mergers, partnerships, and collaborations. For instance, in 2021, Medtronic introduced the Micra AV, a self-contained, miniature pacemaker that uses a minimally invasive technique to deliver improved pacing technology to patients with atrioventricular (AV) block. 'Medtronic', 'Abbott Laboratories', 'Boston Scientific Corporation', 'Biotronik SE & Co. KG', 'LivaNova PLC', 'MicroPort Scientific Corporation', 'Osypka Medical GmbH', 'Shree Pacetronix Ltd.', 'Cook Medical Inc.', 'Integer Holdings Corporation', 'Edwards Lifesciences Corporation', 'ZOLL Medical Corporation', 'Vitatron Holding B.V.', 'Lepu Medical Technology (Beijing) Co., Ltd.', 'Pacetronix Limited', 'NIHON KOHDEN CORPORATION', 'Oscor Inc.', 'Pacetech Corp.', 'Beijing Carejoy Technology Co., Ltd.', 'Sorin Group'

With the global population aging, there is a higher incidence of age-related cardiovascular diseases. Older individuals are more prone to heart rhythm abnormalities, leading to an increased demand for pacemakers.

Technological Advancements: The pacemakers market is witnessing continuous technological advancements. Manufacturers are focusing on developing pacemakers with advanced features like remote monitoring, wireless connectivity, MRI compatibility, and longer battery life. These technological advancements enhance patient convenience, improve device performance, and drive market growth.

In 2022, North America held a commanding 42.0% revenue share in the pacemaker market and dominated it. This rise is brought on by an aging population with cardiac issues, the presence of important players, quick technology breakthroughs like Bluetooth-enabled pacemakers and MRI-compatible pacemakers, as well as better regulatory clearances. The incidence of cardiovascular diseases, such as congestive heart failure, cardiac arrests, and arrhythmias, is rising quickly in the United States, which is fueling the need for pacemakers in the country. Technical advancements in the healthcare sector and a rise in the number of heart-related procedures are also driving the market in the area.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Pacemakers Market

Report ID: SQMIG35A2628

$5,300
BUY NOW GET FREE SAMPLE